420 results on '"González-Gay, Miguel Á"'
Search Results
2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
3. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up
4. Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs
5. Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
6. Serum and genetic markers related to rapid clinical progression of coronary artery disease
7. Marcadores genéticos y séricos relacionados con una rápida progresión clínica de la arteriosclerosis coronaria
8. Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients
9. Systemic treatment in sarcoidosis: Experience over two decades
10. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
11. Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients
12. Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit
13. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes
14. Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
15. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review
16. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
17. The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
18. Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
19. Apolipoprotein C-III in patients with systemic lupus erythematosus
20. Cutaneous Vasculitis
21. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes
22. Epidemiology of sarcoidosis in northern Spain, 1999-2019: A population-based study
23. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review
24. HLA association with the susceptibility to anti-synthetase syndrome
25. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients
26. Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients
27. Obesity and Osteoarthritis: Are Adipokines Bridging Metabolism, Inflammation, and Biomechanics?
28. Atypical presentation of immunoglobulin G4-related disease as subglottic stenosis: a case-based review
29. Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients With Rheumatoid Arthritis.
30. Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease.
31. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease.
32. Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study
33. Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association
34. Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients
35. Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus
36. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
37. Giant Cell Arteritis
38. Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
39. Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
40. Early large vessel systemic vasculitis in adults
41. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
42. Treatment of giant cell arteritis
43. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases
44. Treatment of polymyalgia rheumatica
45. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
46. Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study
47. Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis
48. Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis.
49. Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis.
50. Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.